NIH Brain Development Cohorts Biobank

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH NIDA

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N98026R00106

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AN11

Additional Details
Set Aside

NONE

Place of Performance

-

SourceSAM
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has issued a Sources Sought Notice (Procurement Identifier: 75N98026R00106) seeking capability statements from qualified business organizations for the maintenance and management of the NIH Brain Development Cohorts (NBDC) Biobank. This biobank serves as a critical repository for processing, storing, analyzing, and distributing de-identified biological samples and associated data derived from two major longitudinal studies: the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study and the HEALthy Brain and Child Development (HBCD) Study. **Purpose and Scope** The primary objective of this procurement is to identify organizations capable of providing comprehensive biobanking services for a large-scale, multi-site research initiative. The selected entity will be responsible for the stewardship of over 550,000 biospecimen samples at the outset, with an anticipated intake of approximately 170,000 additional samples over the contract period. The biobank must support a wide array of biospecimen types—including blood, serum, plasma, DNA, RNA, saliva, hair, urine, teeth, fecal matter, placenta, and umbilical cord blood and tissue—requiring storage under various conditions and rigorous quality control. **Key Requirements and Expected Deliverables** Contractors must demonstrate robust experience and technical capability in the following areas: - **Sample and Data Management:** - Safe processing, storage, and tracking of 500,000–700,000 biospecimens. - Distribution of collection kits (with barcoded, human-readable labels) to 48 research sites nationwide. - Training site coordinators and research staff in supply ordering and sample collection. - Maintenance of a positive chain of custody and resolution of data/sample discrepancies. - Centralized, cost-effective distribution of biosamples to qualified investigators via the Biospecimens Access Programs. - **Technical and Informatics Infrastructure:** - Maintenance and updating of databases linking phenotypic/genotypic data with participant/sample IDs. - Management and enhancement of the NBDC Biobank portal, including both front-end and back-end features, to support sample availability, kit ordering, and access program functionalities. - Compliance with FISMA-low and other NIH security requirements. - Development and maintenance of APIs and cyberinfrastructure for secure, interoperable data exchange. - **Laboratory Capabilities:** - Demonstrated expertise in biobanking, LIMS, and database management. - Ability to maintain and develop all aspects of the NBDC Biobank Portal, including backend logic, server maintenance, microservices, PostGreSQL databases, and UI/UX design. - Provision of scientific and technical expertise for evaluating researcher inquiries. - If requested, access to CLIA-certified laboratory capabilities for advanced analyses (metabolic, hematologic, genotyping, sequencing, gene-expression). - **Collaboration and Governance:** - Establishment of strong collaborative relationships with ABCD and HBCD Data Centers and study teams. - Participation as a co-signatory on the Specimen Transfer Agreement. - Eligibility for a Certificate of Confidentiality and adherence to all relevant federal regulations for the protection of sensitive participant information. **Contracting Entity and Classification** - **Contracting Entity:** National Institutes of Health, National Institute on Drug Abuse (NIDA), under the Department of Health and Human Services. - **NAICS Code:** 541714 – Research and Development in Biotechnology (except Nanobiotechnology), with a size standard of 1,000 employees or fewer. - **Product Service Code:** AN11. - **Set-Aside Status:** None; this notice is open to all qualified business concerns. **Submission and Contact Information** Interested organizations must submit detailed capability statements electronically, addressing their experience, personnel qualifications, and facility resources relevant to the requirements outlined above. Submissions should include company name, address, point of contact, SAM.gov UEI, contact information, NAICS code(s), business size/status, and any applicable business designations (e.g., small, veteran-owned, women-owned, 8(a), SDB, HUBZone). - **Primary Contact:** Shaun Rostad, [email protected], 301-594-9516 - **Secondary Contact:** Joshua T. Lazarus, [email protected], 301-827-6923 All responses must be submitted electronically by 1:00 p.m. EST on July 14, 2026. Paper or faxed submissions will not be accepted. **Special Considerations** This is a Sources Sought Notice for information and planning purposes only; it is not a solicitation or request for proposals. The government does not intend to award a contract based on responses to this notice and will not reimburse costs associated with the preparation of submissions. Respondents should ensure their capability statements are comprehensive and sufficiently detailed to demonstrate their qualifications. **Constant Elements Over Contract Lifecycle** The core requirements—large-scale biobank management, secure and compliant informatics infrastructure, advanced laboratory capabilities, and collaborative governance—will remain central throughout the contract period. The biobank’s role as a national resource for the ABCD and HBCD studies, supporting ongoing and future research through expert stewardship of biospecimens and data, is a foundational aspect of this opportunity. For further details and to access the official notice, visit: [SAM.gov Opportunity ID 3ca0882ad93a4a8095a771ac6b728c8e](https://sam.gov/opp/3ca0882ad93a4a8095a771ac6b728c8e/view).